Close Menu
iM.NewsiM.News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    US Loses Measles Elimination Status Amid 2026 Outbreak

    November 17, 2026

    UK Sanctions Firms Over West Bank Settlements

    November 17, 2026

    Why Anguilla Is the Caribbean’s Top Luxury Beach Destination

    November 17, 2026
    Facebook X (Twitter) Instagram
    iM.NewsiM.News
    Subscribe
    • Home
    • Lifestyle

      US Loses Measles Elimination Status Amid 2026 Outbreak

      November 17, 2026

      How to Fix a Soggy Apple Pie Base

      November 17, 2026

      Cannabis Use Disorder Linked to 57% Higher Odds of Suicidal Thoughts

      November 17, 2026

      Why Bologna Disowns Spaghetti Bolognese

      November 17, 2026

      GLP-1 Drugs and Brain Health: What the Evidence Shows

      November 17, 2026
    • Relations

      UK Sanctions Firms Over West Bank Settlements

      November 17, 2026

      Internet Shutdowns Occurred Daily in 2025, Report Finds

      November 17, 2026

      Ukraine Critically Damages Kerch Bridge in Missile Strike

      November 17, 2026

      Albanese joins AI pact ahead of Trump Quad summit

      November 16, 2026

      Microsoft Outage Root Cause: Months-Old Bug Overwhelmed Servers

      November 16, 2026
    • Technology

      Jensen Huang Open to Returning as Nvidia CEO Amid Scandal

      November 17, 2026

      Flipper One Preorders Open at $399 for Pocket Linux Computer

      November 17, 2026

      Nvidia Warns Clients on New US Export Rules

      November 17, 2026

      Fugaku Supercomputer Breach Stole Data for 4,000 Users

      November 17, 2026

      TRMNL Frame: A $1,300 Full-Color E-Paper Art Display

      November 17, 2026
    • Travel & Tourism

      Why Anguilla Is the Caribbean’s Top Luxury Beach Destination

      November 17, 2026

      Dubai Airport Passenger Traffic Plunges 26% Amid Airline Exodus

      November 17, 2026

      European Airlines Face Rising Carbon Costs as Free Permits End

      November 17, 2026

      United Airlines Resolves Tech Outage Amid Travel Chaos

      November 17, 2026

      Belize Travel Guide: Reefs, Rainforests and Maya Ruins

      November 17, 2026
    • Get in Touch
    iM.NewsiM.News
    Home»Lifestyle»Health»Brain Inflammation Blocker Found in Alzheimer’s Study
    Health

    Brain Inflammation Blocker Found in Alzheimer’s Study

    im.newsBy im.newsOctober 7, 2026No Comments3 Mins Read15 Views
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Microscopic view of brain inflammation and P2X7 receptor activity
    Photo: National Museum of Health and Medicine / Wikimedia Commons, CC BY 2.0
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    Researchers at the University of Birmingham have identified a specific biological target that could help reduce harmful inflammation in the brain. The study, published in the journal Brain, focuses on the P2X7 receptor, a protein structure that triggers inflammatory signaling when activated. By blocking this receptor, the team was able to significantly lower inflammation levels in human brain tissue.

    This discovery offers a potential new avenue for treating a wide range of neurological and psychiatric conditions. Neuroinflammation is believed to play a significant role in the progression of diseases such as Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury (TBI). It is also linked to psychiatric conditions including depression and psychosis.

    Targeting the P2X7 Receptor

    The research team, led by Professor Nicholas Barnes, investigated how the P2X7 receptor influences the brain’s immune response. The receptor is known to promote the release of cytokines, which are proteins that regulate inflammatory responses. When the researchers applied a specific antagonist to block the P2X7 receptor, the inflammatory response in the tested human brain tissue dropped significantly.

    Schistosoma japonicum eggs microscope slide (MIS 99 5576 2), National Museum of Health and Medicine
    Photo: National Museum of Health and Medicine / Wikimedia Commons, CC BY 2.0

    Professor Barnes noted that this finding marks a major step toward repurposing existing therapeutics to combat neuroinflammation at its source. The identification of this receptor could have far-reaching implications for some of the most debilitating and widespread brain disorders. These include Alzheimer’s Disease, Parkinson’s, and Multiple Sclerosis, as well as inflammation-linked psychiatric conditions like schizophrenia and depression.

    Developing a Scalable Model for Human Microglia

    A major component of the study involved microglia, the immune cells that coordinate the brain’s response to injury and inflammation. Studying these cells has historically been difficult because they lose their defining characteristics once removed from their native brain environment. To overcome this, the researchers developed a method for converting human peripheral monocytes, a type of white blood cell collected from blood samples, into microglia-like cells.

    A group of scientists working in a laboratory Esculab
    Photo: Esculab / Wikimedia Commons, CC0

    This process mirrors a cellular transformation that occurs naturally in the brain during human aging. The resulting monocyte-derived microglia provided a powerful, scalable, and virtually unlimited platform for studying human microglial biology with unprecedented precision. When the researchers applied the P2X7 receptor antagonist to these cells, they were able to interfere with signals released by microglia as the cells became damaged and died.

    After identifying the response in the lab-grown cells, the team tested whether the same findings could be reproduced in human brain tissue obtained through neurosurgical procedures. The successful results in actual human tissue strengthen the case for further investigation. The next stage for this research is the development of clinical trials in patients with neurodegenerative conditions and patients with TBI, where there are currently no effective pharmacological treatments to reduce the neuroinflammation and arising damage.

    Source: ScienceDaily

    Alzheimer's brain health Health Neuroinflammation P2X7 Parkinson's University of Birmingham
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleUCSF Scientists Reprogram Immune Cells In Vivo to Fight Cancer
    Next Article Sugar Worsens Gut Damage From Antibiotics in Cancer Patients
    im.news

    Related Posts

    US Loses Measles Elimination Status Amid 2026 Outbreak

    November 17, 2026

    UK Sanctions Firms Over West Bank Settlements

    November 17, 2026

    Why Anguilla Is the Caribbean’s Top Luxury Beach Destination

    November 17, 2026
    Leave A Reply Cancel Reply

    Latest Posts

    US Loses Measles Elimination Status Amid 2026 Outbreak

    November 17, 20261 Views

    UK Sanctions Firms Over West Bank Settlements

    November 17, 20262 Views

    Why Anguilla Is the Caribbean’s Top Luxury Beach Destination

    November 17, 20262 Views

    How to Fix a Soggy Apple Pie Base

    November 17, 20262 Views
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025 News Focus 247 Views

    In a stunning development that has sent shockwaves through political and entertainment circles, Attorney General…

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide the daily life news. You find latest trendy news at our portal, from entertainment to economy or politics.

    We're accepting new partnerships right now.

    Email Us: info@im.news

    Facebook X (Twitter) RSS
    Our Picks

    US Loses Measles Elimination Status Amid 2026 Outbreak

    November 17, 2026

    UK Sanctions Firms Over West Bank Settlements

    November 17, 2026

    Why Anguilla Is the Caribbean’s Top Luxury Beach Destination

    November 17, 2026
    Most Popular

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025247 Views

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025208 Views

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025164 Views
    © 2026 I'm News. Designed by I'm News.
    • Home
    • Lifestyle
    • Relations
    • Travel & Tourism
    • Technology

    Type above and press Enter to search. Press Esc to cancel.